A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)

Acta Neurologica Scandinavica

Volumn 126, Issue S195, 2012, Pages 43-50

  Pugliatti, M ^a,b   Casetta, I ^c   Drulovic, J ^d   Granieri, E ^c   Holmoy T ^e,f   Kampman, M T ^g,h   Landtblom, A M ⁱ   Lauer, K ^j   Myhr, K M ^a,k   Parpinel, M ^l   Pekmezovic, T ^d   Riise, T ^a   Zhu, B ^m   Wolfson, C ^m,n  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF OSLO   (Norway)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF TROMSØ   (Norway)

^h UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

^j Haukeland University Hospital ^*

^k HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^l UNIVERSITY OF UDINE   (Italy)

^m RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁿ MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Acceptability; Autoimmune diseases; Case control study; Cross cultural; Environmental factors; Multiple sclerosis; Questionnaire; Reliability

Indexed keywords

VITAMIN D;

ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL RISK FACTORS IN MULTIPLE SCLEROSIS QUESTIONNAIRE; ETHNIC DIFFERENCE; FEASIBILITY STUDY; FOOD INTAKE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MONONUCLEOSIS; MULTIPLE SCLEROSIS; OCCUPATIONAL EXPOSURE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; SMOKING; SUN EXPOSURE;

EID: 84871659581     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12032     Document Type: Article

References (29)

1. Sobocki P, Pugliatti M, Lauer K, Kobelt G. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study. Mult Scler 2007;13:1054-64.
2. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-32.
3. Grønlie SA, Myrvoll E, Hansen G, Grønning M, Mellgren SI. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 2000;247:129-33.
4. Pugliatti M, Cossu P, Sotgiu S, Rosati G, Riise T. Clustering of multiple sclerosis, age of onset and gender in Sardinia. J Neurol Sci 2009;286:6-13.
5. Orton SM, Herrera BM, Yee IM et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-6.
6. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-27.
7. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599-612.
8. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288-99.
9. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-30.
10. Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003;61:1122-4.
11. Holmqvist P, Hammar M, Landtblom AM, Brynhildsen J. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 2010;94:2835-7.
12. Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology 1996;37:278-87.
13. Wolfson C, Riise T. (eds.) The epidemiologic study of exogenous factors in the etiology of multiple sclerosis. Neurology 1997;49(Suppl 2).
14. Boiko A. Data collection. Guidelines for questionnaires to be used in case-control studies of multiple sclerosis. Neurology 1997;49(Suppl 2):S75-80.
15. Edwards P, Roberts I, Clarke M et al. Increasing response rate to postal questionnaires: systematic review. BMJ 2002;324:1183-91.
16. Bradford-Hill A. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
17. Sperber AD. Translation and validation of study instruments for cross-cultural research. Gastroenterology 2004;126:S124-8.
18. Schilling LM, Kozak K, Lundhal K, Dellavalle RP. Inaccessible novel questionnaires in published medical research: hidden methods, hidden costs. Am J Epidemiol 2006;164:1141-4.
19. Rosen T, Olsen J. Invited commentary: the art of making questionnaires better. Am J Epidemiol 2006;164:1145-9.
20. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
21. van der Mei IA, Ponsonby AL, Dwyer T et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316-21.
22. Adams MA, Mayer JA, Bowen DJ, Ji M. Season of interview and self-report of summer sun protection behaviors. Cancer Causes Control 2009;20:153-62.
23. Stunkard AJ, Sorensen TI, Schulsinger F (eds). Use of the Danish adoption register for the study of obesity and thinness. New York: Raven Press, 1983.
24. British Standards. Precision of test methods. Part I. Guide for the determination of 'reproducibility' and reproducibility for a standard test method by interlaboratory tests. British Standard Institution 1987:BS 5497.
25. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measur 1960;20:37-46.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-73.
27. Wolfson C, Wolfson DB. The latent period of multiple sclerosis: a critical review. Epidemiology 1993;4:464-70.
28. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzche PC, Vander Broucke JP, and the STROBE intiative. The Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.
29. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992;135:1019-28.